Clinical Trials Directory

Trials / Unknown

UnknownNCT05305872

Gandouling in the Treatment of Wilson's Disease

The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
240 (estimated)
Sponsor
Jun Li · Academic / Other
Sex
All
Age
15 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To evaluate the efficacy and safety of gandouling tablet in the treatment of clinical symptoms of Wilson's diasease.

Detailed description

To evaluate the efficacy and safety of gandouling tablet in the treatment of clinical symptoms of Wilson's diasease.Test various indicatorsbefore test, 4 weeks, 12 weeks and 24 weeks.

Conditions

Interventions

TypeNameDescription
DRUGGandoulingThe experimental group was given gandouling tablet + zinc gluconate simulant; The course of treatment was 24 weeks.

Timeline

Start date
2023-01-01
Primary completion
2023-03-01
Completion
2024-12-31
First posted
2022-03-31
Last updated
2024-02-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05305872. Inclusion in this directory is not an endorsement.